rss
Evid Based Nurs 2:73 doi:10.1136/ebn.2.3.73
  • Treatment

Antenatal oral dexamethasone for neonatal respiratory distress syndrome increased neonatal morbidity


 
 Question Is antenatal oral dexamethasone as efficacious and safe as intramuscular dexamethasone for reducing neonatal respiratory distress syndrome?

Design

Randomised controlled trial.

Setting

USA.

Patients

170 women who were 24–33 weeks gestation and had preterm labour, preterm rupture of membranes, or a medical indication for delivery. Women were excluded if they had previously received corticosteroids during the pregnancy, had received anticonvulsant treatment or rifampin, had an infection other than cystitis or cervicitis, had advanced cervical dilation (≥5 cm), or had known fetal pulmonary maturity through amniocentesis or vaginal pool sampling. 5 women were unavailable for follow up.

Intervention

Women were allocated to dexamethasone, 8 mg orally (n=92) or dexamethasone, 6 mg intramuscularly (n=78) every 12 hours for 4 doses. The regimen was repeated weekly until 34 weeks gestation if delivery had not yet occurred.

Main outcome measures

Main outcome was neonatal …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article